Showing results (351-360 of 548) with videos related to
Sort By:
Pageof 55
Circulation|March 21, 2007
High-density lipoprotein and the risk of recurrent venous thromboembolismSabine Eichinger, Natalie M Pecheniuk, Gregor Hron, et al.Journal of Thrombosis and Haemostasis : JTH|May 14, 2014
Improved hemostasis in hemophilia mice by means of an engineered factor Va mutantA von Drygalski, T J Cramer, V Bhat, et al.Blood Advances|January 4, 2018
Activated protein C light chain provides an extended binding surface for its anticoagulant cofactor, protein SJosé A Fernández, Xiao Xu, Ranjeet K Sinha, et al.Stroke|July 20, 2012
An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodentsYaoming Wang, Zhenggang Zhang, Nienwen Chow, et al.Biochemistry|July 17, 1990
Orientation of the putative recognition helix in the DNA-binding domain of Hin recombinase complexed with the hix siteD P Mack, J P Sluka, J A Shin, et al.Thrombosis Research|July 23, 2011
Activated protein C plasma levels in the fasting and postprandial states among patients with previous unprovoked venous thromboembolismJohn-Bjarne Hansen, José A Fernández, Knut H Borch, et al.Stroke|July 1, 1996
Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutationM Fisher, J A Fernandez, S F Ameriso, et al.Horticulture Research|September 5, 2022
An eco-evo-devo genetic network model of stress responseLi Feng, Tianyu Dong, Peng Jiang, et al.Biomaterials Advances|December 21, 2024
Macrophage and osteosarcoma cell crosstalk is dependent on oxygen tension and 3D cultureKatherine H Griffin, Isabel S Sagheb, Thomas P Coonan, et al.Blood Advances|December 8, 2022
Thrombin-mediated activation of PAR1 enhances doxorubicin-induced cardiac injury in miceSteven P Grover, Vanthana Bharathi, Jens J Posma, et al.Pageof 55